Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNausea is the most commonly reported side effect of Wegovy, and it tends to be most noticeable in the first few weeks of treatment or after a dose increase. For most people it settles on its own as the body adjusts. Understanding why it happens, and a few practical ways to manage it, makes the experience a good deal less alarming. Wegovy is a prescription-only medicine; a clinical assessment is needed before starting, and your prescriber is the right person to guide any changes to your treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide — the active ingredient in Wegovy — works partly by slowing gastric emptying, which is the rate at which food moves from your stomach into the small intestine. That slowdown is intentional: it extends the feeling of fullness and reduces appetite. The downside, especially early on, is that food can sit in the stomach longer than it used to, which is the direct source of that queasy, unsettled feeling that many people describe.
The NHS medicines page for semaglutide lists nausea, vomiting, diarrhoea and constipation as the most common effects, and notes they are generally mild to moderate and tend to improve with time. This is consistent with what was reported during the clinical trials that led to Wegovy's UK licence. The nausea rarely appears and stays at the same intensity; for most people it follows a curve: noticeable at first, then fading as the body recalibrates.
Knowing the mechanism matters because it changes how you respond. This isn't an allergy or a sign something has gone wrong with your medicine. It's your digestive system encountering a new signal and taking a few weeks to accommodate it. That framing tends to make the early weeks more manageable, even if the nausea itself is uncomfortable.
There is a straightforward pattern that comes up repeatedly in clinical guidance: people who feel sick on Wegovy often report that large meals, fatty foods and eating quickly make things noticeably worse. The stomach is already slower than usual; a large or heavy meal amplifies that sluggishness.
Practical steps that genuinely help, and that align with the NHS's own guidance, include eating smaller portions more frequently rather than two or three large meals, choosing lower-fat and lower-fibre options in the early adjustment weeks (high-fibre meals can add to feelings of bloating and fullness), staying upright for at least 30 minutes after eating, eating slowly and stopping before you feel completely full, and keeping well hydrated between rather than during meals.
If eating after your injection makes symptoms worse, some people find it helpful to think about timing, though any adjustment to how you take your medication should be confirmed with your prescriber first. If you are looking for practical strategies around feeling sick after eating on Wegovy, our guide on how to stop feeling sick on Wegovy covers that pattern in depth.
One thing our prescribers hear most weeks: patients who switched to blander, smaller meals in the first dose-increase week were surprised at how quickly the worst of the nausea passed. It often is that straightforward.
Mild to moderate nausea that comes and goes is expected. Certain symptoms are not, and it is important to be clear about the line between them.
Seek urgent medical help if you experience severe, persistent stomach pain that radiates to your back, with or without vomiting. This pattern can indicate acute pancreatitis, which is a known but infrequent risk with GLP-1 medicines. The MHRA issued a specific Drug Safety Update on this in January 2026, reinforcing that patients and clinicians should be alert to it. You should also get prompt medical attention if vomiting is severe enough to prevent you from keeping fluids down for more than 24 hours, if you show signs of dehydration such as dizziness, dark urine or reduced urination, or if you develop symptoms of a serious allergic reaction.
For other side effects that tend to travel alongside nausea, people sometimes notice unusual fatigue or feeling cold, a side effect our dedicated page covers in detail alongside its causes, and our Wegovy side effects page covers those patterns more broadly. You can also report any suspected side effect directly to the MHRA through the Yellow Card reporting service, which helps build the post-market safety picture for medicines like Wegovy.
For the majority of people who experience nausea on Wegovy, the sharpest phase is the first two to four weeks at any given dose. As dose increases happen over the treatment schedule, nausea can briefly return, then ease again. If you are approaching a dose change and already feeling sick regularly, that is a reasonable thing to raise with your prescriber ahead of the increase, they may adjust the pace of titration rather than push through.
Nausea that is genuinely severe, that has not improved after two to three weeks, or that is preventing you from eating and drinking adequately is not something to manage alone. Contact your prescriber or pharmacy's aftercare team. Slowing titration or temporarily holding at a lower dose is a recognised clinical approach, and it does not mean the medicine has failed.
Understanding the full side-effect picture helps put nausea in context, and if you have also been wondering whether the tiredness you feel is connected to the medication, our page on semaglutide and fatigue covers the broader range of what people experience across the treatment course, including how effects shift at different doses. If you are at an early stage of exploring your options, our weight-loss treatment overview explains what is available in the UK and how private treatment works.
If you have questions about whether Wegovy is clinically suitable for you, or want to discuss your current symptoms with a prescriber, you are welcome to start a free consultation with our clinical team.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.